AbbVie Inc.ABBVNYSE
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P36
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-5.03%
202414.61%
2023-15.65%
202223.57%
20219.29%
202062.76%
2019-6.18%
201817.54%
20177.04%
2016-7.92%